82 related articles for article (PubMed ID: 8161210)
1. Triplex forming ability of a c-myc promoter element predicts promoter strength.
Firulli AB; Maibenco DC; Kinniburgh AJ
Arch Biochem Biophys; 1994 Apr; 310(1):236-42. PubMed ID: 8161210
[TBL] [Abstract][Full Text] [Related]
2. The dynamic character of the G-quadruplex element in the c-MYC promoter and modification by TMPyP4.
Seenisamy J; Rezler EM; Powell TJ; Tye D; Gokhale V; Joshi CS; Siddiqui-Jain A; Hurley LH
J Am Chem Soc; 2004 Jul; 126(28):8702-9. PubMed ID: 15250722
[TBL] [Abstract][Full Text] [Related]
3. A nuclease hypersensitive element in the human c-myc promoter adopts several distinct i-tetraplex structures.
Simonsson T; Pribylova M; Vorlickova M
Biochem Biophys Res Commun; 2000 Nov; 278(1):158-66. PubMed ID: 11071868
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of transcription of the human c-myc protooncogene by intermolecular triplex.
Kim HG; Reddoch JF; Mayfield C; Ebbinghaus S; Vigneswaran N; Thomas S; Jones DE; Miller DM
Biochemistry; 1998 Feb; 37(8):2299-304. PubMed ID: 9485376
[TBL] [Abstract][Full Text] [Related]
5. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription.
Siddiqui-Jain A; Grand CL; Bearss DJ; Hurley LH
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11593-8. PubMed ID: 12195017
[TBL] [Abstract][Full Text] [Related]
6. Human amiloride-sensitive epithelial Na+ channel gamma subunit promoter: functional analysis and identification of a polypurine-polypyrimidine tract with the potential for triplex DNA formation.
Auerbach SD; Loftus RW; Itani OA; Thomas CP
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):105-14. PubMed ID: 10727408
[TBL] [Abstract][Full Text] [Related]
7. A protein binding site from the murine c-myc promoter contributes to transcriptional block.
Dufort D; Drolet M; Nepveu A
Oncogene; 1993 Jan; 8(1):165-71. PubMed ID: 8423994
[TBL] [Abstract][Full Text] [Related]
8. Intra- and intermolecular triplex DNA formation in the murine c-myb proto-oncogene promoter are inhibited by mithramycin.
Vigneswaran N; Thayaparan J; Knops J; Trent J; Potaman V; Miller DM; Zacharias W
Biol Chem; 2001 Feb; 382(2):329-42. PubMed ID: 11308031
[TBL] [Abstract][Full Text] [Related]
9. Influence of GC and AT specific DNA minor groove binding drugs on intermolecular triplex formation in the human c-Ki-ras promoter.
Vigneswaran N; Mayfield CA; Rodu B; James R; Kim HG; Miller DM
Biochemistry; 1996 Jan; 35(4):1106-14. PubMed ID: 8573565
[TBL] [Abstract][Full Text] [Related]
10. The identification of a tandem H-DNA structure in the c-myc nuclease sensitive promoter element.
Firulli AB; Maibenco DC; Kinniburgh AJ
Biochem Biophys Res Commun; 1992 May; 185(1):264-70. PubMed ID: 1599463
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
Napoli S; Negri U; Arcamone F; Capobianco ML; Carbone GM; Catapano CV
Nucleic Acids Res; 2006; 34(2):734-44. PubMed ID: 16449206
[TBL] [Abstract][Full Text] [Related]
12. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
13. Thermodynamics of i-tetraplex formation in the nuclease hypersensitive element of human c-myc promoter.
Mathur V; Verma A; Maiti S; Chowdhury S
Biochem Biophys Res Commun; 2004 Aug; 320(4):1220-7. PubMed ID: 15249220
[TBL] [Abstract][Full Text] [Related]
14. The promoter of the C1 inhibitor gene contains a polypurine.polypyrimidine segment that enhances transcriptional activity.
Zahedi K; Bissler JJ; Prada AE; Prada JA; Davis AE
J Immunol; 1999 Jun; 162(12):7249-55. PubMed ID: 10358172
[TBL] [Abstract][Full Text] [Related]
15. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
[TBL] [Abstract][Full Text] [Related]
16. (A,G)-oligonucleotides form extraordinary stable triple helices with a critical R.Y sequence of the murine c-Ki-ras promoter and inhibit transcription in transfected NIH 3T3 cells.
Alunni-Fabbroni M; Pirulli D; Manzini G; Xodo LE
Biochemistry; 1996 Dec; 35(50):16361-9. PubMed ID: 8973212
[TBL] [Abstract][Full Text] [Related]
17. The cis-acting elements known to regulate c-myc expression ex vivo are not sufficient for correct transcription in vivo.
Lavenu A; Pournin S; Babinet C; Morello D
Oncogene; 1994 Feb; 9(2):527-36. PubMed ID: 8290263
[TBL] [Abstract][Full Text] [Related]
18. Modulation of c-myc transcription by triple helix formation.
Postel EH
Ann N Y Acad Sci; 1992 Oct; 660():57-63. PubMed ID: 1340156
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of the enhancer blocking element of the sea urchin early histone gene cluster reveals insulator properties and three essential cis-acting sequences.
Melfi R; Palla F; Di Simone P; Alessandro C; Calì L; Anello L; Spinelli G
J Mol Biol; 2000 Dec; 304(5):753-63. PubMed ID: 11124024
[TBL] [Abstract][Full Text] [Related]
20. c-MYC repression of promoter activity through core promoter elements.
Lucas JM; Wilkie NM; Lang JC
Biochem Biophys Res Commun; 1993 Aug; 194(3):1446-52. PubMed ID: 8352803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
